These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 24171822)

  • 1. Status of anti-lung cancer drug patents applications in China from 2003 to 2012.
    Chen DM; Mao KY; Yang L; Jiang HB
    Recent Pat Anticancer Drug Discov; 2014 May; 9(2):221-40. PubMed ID: 24171822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of patents on anti-allergic therapies issued in China from 1988 to 2008.
    Zhang S; Zeng X; Wei J; Li S; He S
    Expert Opin Ther Pat; 2010 Jun; 20(6):727-37. PubMed ID: 20476846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of trends and opportunities of anti-allergy patents in China from 1998 to 2008.
    Zhang S; Zeng X; Wei J; Li S; He S
    Recent Pat Inflamm Allergy Drug Discov; 2010 Jun; 4(2):130-7. PubMed ID: 20394584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of patents on anti-gout therapies issued in China.
    Yuan HY; Zhang XH; Zhang XL; Wei JF; Meng L
    Expert Opin Ther Pat; 2014 May; 24(5):555-72. PubMed ID: 24605811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An update on anti-allergic patents granted in China: 2009 - 2011.
    Zhang S; Zeng X; He S
    Expert Opin Ther Pat; 2012 Jul; 22(7):715-34. PubMed ID: 22702413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of Patents Issued in China for Antihyperglycemic Therapies for Type 2 Diabetes Mellitus.
    Zhu W; Huang W; Xu Z; Cao M; Hu Q; Pan C; Guo M; Wei JF; Yuan H
    Front Pharmacol; 2019; 10():586. PubMed ID: 31214029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of patents on anti-rheumatoid arthritis therapies issued in China.
    Yuan HY; Zhang XL; Zhang XH; Meng L; Wei JF
    Expert Opin Ther Pat; 2015; 25(8):909-30. PubMed ID: 26066366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of radio-sensitization patents in China from 2006 to 2015.
    He G; Di X; Sun X; Yan J; Zhang S
    Expert Opin Ther Pat; 2017 Oct; 27(10):1159-1172. PubMed ID: 28621575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of anti-asthmatic drug patents published in China between 2004 and 2013.
    Xie H; Zhang H; Cao K; He P; Dai H; He S
    Expert Opin Ther Pat; 2016; 26(3):363-76. PubMed ID: 26742645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of compound Chinese medicine in the treatment of lung cancer.
    Tian G; Guo L; Gao W
    Curr Drug Discov Technol; 2010 Mar; 7(1):32-6. PubMed ID: 20156141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Value and influencing factors of valid Traditional Chinese Medicine compound prescription patents for mammary gland hyperplasia.
    Xujie Y; Xiaohua P
    J Tradit Chin Med; 2022 Dec; 42(6):1012-1018. PubMed ID: 36378061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Review of experimental study on treatment of lung cancer with traditional Chinese medicine].
    Yang D; Tian G
    Zhongguo Zhong Yao Za Zhi; 2009 Sep; 34(18):2405-9. PubMed ID: 20030099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacovigilance practice and risk control of Traditional Chinese Medicine drugs in China: current status and future perspective.
    Zhang L; Yan J; Liu X; Ye Z; Yang X; Meyboom R; Chan K; Shaw D; Duez P
    J Ethnopharmacol; 2012 Apr; 140(3):519-25. PubMed ID: 22374080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. INGN 201: Ad-p53, Ad5CMV-p53, adenoviral p53, p53 gene therapy--introgen, RPR/INGN 201.
    Drugs R D; 2007; 8(3):176-87. PubMed ID: 17472413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Regional development of patents of traditional Chinese medicine compounds on basis of cluster analysis].
    Yang X; Xiao S
    Zhongguo Zhong Yao Za Zhi; 2012 Aug; 37(16):2472-7. PubMed ID: 23234153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Analysis of patent data of Panax notoginseng and enlightenment of industrial development].
    Li G; Chen J; Li ZK; Wu W; Yang HJ
    Zhongguo Zhong Yao Za Zhi; 2020 Mar; 45(5):1011-1022. PubMed ID: 32237440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Analyses on positive influence of harmonous development of traditional Chinese medicine compounds' researchs and patent protection].
    Yang X; Xiao S; Guo Z; Wang Z; You Y
    Zhongguo Zhong Yao Za Zhi; 2012 Jan; 37(1):9-12. PubMed ID: 22741453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of antibiotic patents issued in China from 1992 to 2011.
    Xie H; Zhang H; Zhang S; He S
    Expert Opin Ther Pat; 2012 Oct; 22(10):1205-32. PubMed ID: 22957903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efaproxiral: GSJ 61, JP 4, KDD 86, RS 4, RSR 13.
    Drugs R D; 2005; 6(3):178-85. PubMed ID: 15869322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Traditional Chinese medicine formulas for the treatment of osteoporosis: Implication for antiosteoporotic drug discovery.
    Zhang ND; Han T; Huang BK; Rahman K; Jiang YP; Xu HT; Qin LP; Xin HL; Zhang QY; Li YM
    J Ethnopharmacol; 2016 Aug; 189():61-80. PubMed ID: 27180315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.